Literature DB >> 24054138

Tyrosine hydroxylase: regulation by feedback inhibition and phosphorylation.

Phillip W Dickson1, Gabrielle D Briggs.   

Abstract

Tyrosine hydroxylase (TH) is the rate-limiting enzyme in the biosynthesis of the catecholamines dopamine, noradrenaline, and adrenaline. In response to short-term stimuli, TH activity is regulated by feedback inhibition by the catecholamines and relief of that inhibition by phosphorylation. This chapter examines the current understanding of these regulatory mechanisms and the roles that they play in different catecholaminergic cells. This chapter also examines hierarchical phosphorylation in TH and how it provides a mechanism for the differential regulation of the major human TH isoforms.
© 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Feedback inhibition; Hierarchical; Human; Isoforms; Phosphorylation; Tyrosine hydroxylase

Mesh:

Substances:

Year:  2013        PMID: 24054138     DOI: 10.1016/B978-0-12-411512-5.00002-6

Source DB:  PubMed          Journal:  Adv Pharmacol        ISSN: 1054-3589


  16 in total

Review 1.  Cerebral Toxocariasis: Silent Progression to Neurodegenerative Disorders?

Authors:  Chia-Kwung Fan; Celia V Holland; Karen Loxton; Ursula Barghouth
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

Review 2.  Complex molecular regulation of tyrosine hydroxylase.

Authors:  Izel Tekin; Robert Roskoski; Nurgul Carkaci-Salli; Kent E Vrana
Journal:  J Neural Transm (Vienna)       Date:  2014-05-28       Impact factor: 3.575

3.  Nucleotide sequence conservation of novel and established cis-regulatory sites within the tyrosine hydroxylase gene promoter.

Authors:  Meng Wang; Kasturi Banerjee; Harriet Baker; John W Cave
Journal:  Front Biol (Beijing)       Date:  2015-02-01

4.  L-Tyrosine availability affects basal and stimulated catecholamine indices in prefrontal cortex and striatum of the rat.

Authors:  Zachary D Brodnik; Manda Double; Rodrigo A España; George E Jaskiw
Journal:  Neuropharmacology       Date:  2017-05-29       Impact factor: 5.250

5.  Molecular Features of Parkinson's Disease in Patient-Derived Midbrain Dopaminergic Neurons.

Authors:  Yong Ren; Houbo Jiang; Jiali Pu; Li Li; Jianbo Wu; Yaping Yan; Guohua Zhao; Thomas J Guttuso; Baorong Zhang; Jian Feng
Journal:  Mov Disord       Date:  2021-09-26       Impact factor: 10.338

6.  Early life peripheral lipopolysaccharide challenge reprograms catecholaminergic neurons.

Authors:  Lin Kooi Ong; Erin A Fuller; Luba Sominsky; Deborah M Hodgson; Peter R Dunkley; Phillip W Dickson
Journal:  Sci Rep       Date:  2017-01-10       Impact factor: 4.379

7.  Spontaneously Hypertensive Rats (SHR) Are Resistant to a Reserpine-Induced Progressive Model of Parkinson's Disease: Differences in Motor Behavior, Tyrosine Hydroxylase and α-Synuclein Expression.

Authors:  Anderson H F F Leão; Ywlliane S R Meurer; Anatildes F da Silva; André M Medeiros; Clarissa L C Campêlo; Vanessa C Abílio; Rovena C G K Engelberth; Jeferson S Cavalcante; Geison S Izídio; Alessandra M Ribeiro; Regina H Silva
Journal:  Front Aging Neurosci       Date:  2017-03-27       Impact factor: 5.750

8.  Chronic Blockade of Brain Endothelin Receptor Type-A (ETA) Reduces Blood Pressure and Prevents Catecholaminergic Overactivity in the Right Olfactory Bulb of DOCA-Salt Hypertensive Rats.

Authors:  Luis R Cassinotti; María J Guil; Mercedes I Schöller; Mónica P Navarro; Liliana G Bianciotti; Marcelo S Vatta
Journal:  Int J Mol Sci       Date:  2018-02-27       Impact factor: 5.923

9.  TLR4 signaling in VTA dopaminergic neurons regulates impulsivity through tyrosine hydroxylase modulation.

Authors:  L Aurelian; K T Warnock; I Balan; A Puche; H June
Journal:  Transl Psychiatry       Date:  2016-05-17       Impact factor: 6.222

10.  Binge-Like Alcohol Exposure During Adolescence Disrupts Dopaminergic Neurotransmission in the Adult Prelimbic Cortex.

Authors:  Heather Trantham-Davidson; Samuel W Centanni; S Corrin Garr; Natasha N New; Patrick J Mulholland; Justin T Gass; Elizabeth J Glover; Stan B Floresco; Fulton T Crews; Harish R Krishnan; Subhash C Pandey; L Judson Chandler
Journal:  Neuropsychopharmacology       Date:  2016-09-13       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.